Skip to navigationSkip to main contentSkip to right columnADVERTISEMENTTrefis TeamSat, July 18, 2026 at 12:56 AM GMT+2 3 min readPhoto by 127071 on PixabayThe healthcare giant's stock jump was about more than an earnings beat, offering proof of a growth story broader and more resilient than you thought.You could be forgiven for feeling a little nervous about Abbott Laboratories (ABT) heading into Thursday. The stock had been slipping, and whispers of a slowdown in hospital procedures were getting louder across the healthcare sector. Then the market opened, and Abbott surged +10.7% while the S&P 500 sagged.So what changed overnight? The company delivered more than a simple earnings beat; it provided a direct answer to the market's biggest anxieties.How Did Abbott Defy The Gloom?On the surface, the news was straightforward: Abbott posted adjusted earnings of $1.31 per share, clearing expectations of $1.28. More importantly, the company nudged its full-year profit forecast higher, now expecting between $5.45 and $5.60 per share. That confidence comes from seeing its overall sales growth accelerate to 4.8%, a faster clip than in the prior two quarters. But the real story is where that confidence is coming from, and it's not the place everyone has been watching.If Not Libre, Then What's Driving The Bus?For years, the main character in